Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B438bc951d5b0947f01beb4bc7262d28a> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B438bc951d5b0947f01beb4bc7262d28a NCIT_P378 "NCI" @default.
- B438bc951d5b0947f01beb4bc7262d28a type Axiom @default.
- B438bc951d5b0947f01beb4bc7262d28a annotatedProperty IAO_0000115 @default.
- B438bc951d5b0947f01beb4bc7262d28a annotatedSource NCIT_C171034 @default.
- B438bc951d5b0947f01beb4bc7262d28a annotatedTarget "A preparation of T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD37 (cluster of differentiation 37), with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD37-CAR T-cells specifically recognize and kill CD37-expressing tumor cells. CD37, a member of the tetraspanin superfamily of cell surface antigens, is expressed in B-cell non-Hodgkin lymphomas (NHL), in chronic lymphocytic leukemia (CLL), and in some cases of cutaneous and peripheral T-cell lymphomas. It plays a key role in tumor cell proliferation." @default.